Crossmark Global Holdings’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34M Buy
264,831
+19,645
+8% +$2.3M 0.44% 44
2026
Q1
$29.5M Buy
245,186
+9,280
+4% +$1.07M 0.44% 50
2025
Q4
$24.8M Sell
235,906
-19,298
-8% -$1.81M 0.36% 59
2025
Q3
$21.4M Buy
255,204
+7,394
+3% +$609K 0.32% 71
2025
Q2
$19.6M Sell
247,810
-2,198
-0.9% -$175K 0.32% 69
2025
Q1
$22.4M Buy
250,008
+7,288
+3% +$680K 0.4% 53
2024
Q4
$24.1M Sell
242,720
-3,694
-1% -$381K 0.44% 44
2024
Q3
$28M Buy
246,414
+57,106
+30% +$6.78M 0.5% 37
2024
Q2
$23.4M Buy
189,308
+6,110
+3% +$787K 0.45% 41
2024
Q1
$24.2M Sell
183,198
-8,316
-4% -$1.03M 0.46% 44
2023
Q4
$20.9M Buy
191,514
+6,915
+4% +$718K 0.43% 43
2023
Q3
$19.1M Sell
184,599
-23,249
-11% -$2.51M 0.43% 44
2023
Q2
$22.1M Buy
207,848
+14,978
+8% +$1.7M 0.48% 34
2023
Q1
$20.5M Buy
192,870
+14,909
+8% +$1.61M 0.48% 32
2022
Q4
$19.7M Sell
177,961
-35,169
-17% -$3.59M 0.49% 33
2022
Q3
$18.4M Buy
213,130
+17,927
+9% +$1.6M 0.51% 29
2022
Q2
$17.8M Buy
195,203
+24,002
+14% +$2.13M 0.46% 40
2022
Q1
$14M Sell
171,201
-11,587
-6% -$914K 0.31% 74
2021
Q4
$14M Buy
182,788
+2,508
+1% +$200K 0.3% 81
2021
Q3
$13.5M Sell
180,280
-1,078
-0.6% -$82K 0.32% 75
2021
Q2
$14.1M Buy
181,358
+123,735
+215% +$9.2M 0.33% 65
2021
Q1
$4.24M Buy
57,623
+4,248
+8% +$313K 0.11% 209
2020
Q4
$4.17M Sell
53,375
-1,389
-3% -$106K 0.11% 208
2020
Q3
$4.33M Sell
54,764
-1,355
-2% -$106K 0.12% 184
2020
Q2
$4.14M Buy
56,119
+1,296
+2% +$97.6K 0.12% 184
2020
Q1
$4.03M Sell
54,823
-1,102
-2% -$86.6K 0.14% 161
2019
Q4
$4.85M Buy
55,925
+591
+1% +$48.5K 0.13% 178
2019
Q3
$4.45M Sell
55,334
-12,041
-18% -$965K 0.13% 192
2019
Q2
$5.39M Buy
67,375
+721
+1% +$55.2K 0.15% 164
2019
Q1
$5.29M Sell
66,654
-2,069
-3% -$155K 0.15% 170
2018
Q4
$5.01M Buy
68,723
+1,970
+3% +$139K 0.16% 168
2018
Q3
$4.52M Buy
66,753
+5,177
+8% +$330K 0.11% 211
2018
Q2
$3.57M Sell
61,576
-12,555
-17% -$708K 0.1% 242
2018
Q1
$3.85M Sell
74,131
-2,634
-3% -$142K 0.1% 249
2017
Q4
$4.12M Sell
76,765
-565
-0.7% -$31.3K 0.1% 252
2017
Q3
$4.72M Buy
+77,330
New +$4.69M 0.12% 204
2016
Q3
$4.72M Buy
+77,330
New +$4.52M 0.12% 204

Other funds holding MRK

Crossmark Global Holdings's MRK Position: Q2 2026 in Review

Crossmark Global Holdings increased its Merck (MRK) stake by 8% in Q2 2026, buying an estimated $2.3M and bringing the position to 264,831 shares worth $34M. The position accounts for 0.44% of the portfolio, ranked #44.

Crossmark Global Holdings first reported a position in MRK in Q3 2016 and has held it in 37 quarters since. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crossmark Global Holdings held 264,831 shares of Merck worth $34M as of Q2 2026.
  • Crossmark Global Holdings bought 19,645 Merck shares in Q2 2026, an estimated $2.3M.
  • Merck made up 0.44% of Crossmark Global Holdings's portfolio in Q2 2026, its #44 holding.
  • Crossmark Global Holdings first reported a position in Merck in Q3 2016 and has held it in 37 quarters since.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.